Literature DB >> 12614311

Emergence and progress of white matter lesion in brain check-up.

Y Masana1, T Motozaki.   

Abstract

White matter lesion (WML) is thought to emerge and progress with increasing age but has not yet been well investigated. In this study of WML, risk factors and prevalence added to emergence rate (%/person year) and progress speed [increase of leukoencephalopathy score (LES)/person year] were investigated in 1674 brain check-up subjects from August 1993 to August 2001. Significant (P < 0.01) risk factors were aging and hypertension. Prevalence rate (%) was 0 in 20-29 years, 1.4 in 30-39 years, 4.2 in 40-49 years, 20.9 in 50-59 years, 42.6 in 60-69 years, and 73.9 in 70-years. Emergence rate was 0 in 20-29 years, 0.7 in 30-39 years, 1.5 in 40-49 years, 3.4 in 50-59 years, 6.0 in 60-69 years, and 20 in 70-years. And progress speed was 0.12 in 40-49 years, 0.15 in 50-59 years, 0.21 in 60-69 years, and 0.21 in 70-years. WML begins to emerge early in middle age and both prevalence and severity increase with age.

Entities:  

Mesh:

Year:  2003        PMID: 12614311     DOI: 10.1034/j.1600-0404.2003.02021.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  2 in total

1.  A 10-year longitudinal study of deep white matter lesions on magnetic resonance imaging.

Authors:  Aiko Tamura; Nagato Kuriyama; Kentaro Akazawa; Etsuko Ozaki; Isao Watanabe; Yoichi Ohshima; Masaki Kondo; Nobuo Takezawa; Akihiro Takada; Sanae Matsumoto; Kazuo Takeda; Kengo Yoshii; Kei Yamada; Yoshiyuki Watanabe; Masanori Nakagawa; Toshiki Mizuno
Journal:  Neuroradiology       Date:  2021-02-18       Impact factor: 2.804

2.  Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure.

Authors:  Michael J Firbank; Rebecca M Wiseman; Emma J Burton; Brian K Saxby; John T O'Brien; Gary A Ford
Journal:  J Neurol       Date:  2007-04-20       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.